Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): A protocol for a sham-controlled clinical trial.

Jones HN, Kuchibhatla M, Crisp KD, Hobson Webb LD, Case L, Batten MT, Marcus JA, Kravitz RM, Kishnani PS.

Mol Genet Metab. 2019 May 8. pii: S1096-7192(19)30213-6. doi: 10.1016/j.ymgme.2019.05.001. [Epub ahead of print] Spanish.

PMID:
31303277
2.

The power of public health officers to curb greenhouse gas emissions.

Tait P, Batten M, Deakin M, Van Zeyl M, Weber J.

Aust N Z J Public Health. 2019 Jun;43(3):300-301. doi: 10.1111/1753-6405.12898. Epub 2019 Apr 17. No abstract available.

PMID:
30994952
3.

End-of-life care in an Australian acute hospital: A retrospective observational study.

Maubach N, Batten M, Jones S, Chen J, Scholz B, Davis A, Bromley J, Burke B, Tan R, Hurwitz M, Rodgers H, Mitchell I.

Intern Med J. 2019 Mar 25. doi: 10.1111/imj.14305. [Epub ahead of print]

PMID:
30908873
4.

Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials.

Edwards J, Tasker A, Pires da Silva I, Quek C, Batten M, Ferguson A, Allen R, Allanson B, Saw RPM, Thompson JF, Menzies AM, Palendira U, Wilmott JS, Long GV, Scolyer RA.

Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011. Epub 2019 Feb 18.

PMID:
30777877
5.

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.

Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS.

Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003.

PMID:
30753825
6.

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.

Lee H, Quek C, Silva I, Tasker A, Batten M, Rizos H, Lim SY, Nur Gide T, Shang P, Attrill GH, Madore J, Edwards J, Carlino MS, Guminski A, Saw RPM, Thompson JF, Ferguson PM, Palendira U, Menzies AM, Long GV, Scolyer RA, Wilmott JS.

Oncoimmunology. 2018 Oct 31;8(2):e1537581. doi: 10.1080/2162402X.2018.1537581. eCollection 2019.

PMID:
30713793
7.

Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas.

Silva IPD, Batten M, Long GV.

Br J Cancer. 2018 Sep;119(6):661-662. doi: 10.1038/s41416-018-0218-3. Epub 2018 Aug 21. No abstract available.

PMID:
30131552
8.

End-of-life care of oncology inpatients: Are we getting it right?

Batten M, Nguyen B, Burke B, Harryanto H, Mitchell I, Davis A.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e528-e534. doi: 10.1111/ajco.13001. Epub 2018 Jun 13.

PMID:
29900665
9.

GPR65 inhibits experimental autoimmune encephalomyelitis through CD4+ T cell independent mechanisms that include effects on iNKT cells.

Wirasinha RC, Vijayan D, Smith NJ, Parnell GP, Swarbrick A, Brink R, King C, Stewart G, Booth DR, Batten M.

Immunol Cell Biol. 2018 Feb;96(2):128-136. doi: 10.1111/imcb.1031. Epub 2017 Dec 19.

PMID:
29363187
10.

Cytosolic Recognition of RNA Drives the Immune Response to Heterologous Erythrocytes.

Loetsch C, Warren J, Laskowski A, Vazquez-Lombardi R, Jandl C, Langley DB, Christ D, Thorburn DR, Ryugo DK, Sprent J, Batten M, King C.

Cell Rep. 2017 Nov 7;21(6):1624-1638. doi: 10.1016/j.celrep.2017.10.044.

11.

Implementation of a Hydrotherapy Protocol to Improve Postpartum Pain Management.

Batten M, Stevenson E, Zimmermann D, Isaacs C.

J Midwifery Womens Health. 2017 Mar;62(2):210-214. doi: 10.1111/jmwh.12580. Epub 2017 Apr 4.

PMID:
28376565
12.

IL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque Mice.

Vijayan D, Mohd Redzwan N, Avery DT, Wirasinha RC, Brink R, Walters G, Adelstein S, Kobayashi M, Gray P, Elliott M, Wong M, King C, Vinuesa CG, Ghilardi N, Ma CS, Tangye SG, Batten M.

J Immunol. 2016 Oct 15;197(8):3008-3017. Epub 2016 Sep 12.

13.

Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk.

Lassen KG, McKenzie CI, Mari M, Murano T, Begun J, Baxt LA, Goel G, Villablanca EJ, Kuo SY, Huang H, Macia L, Bhan AK, Batten M, Daly MJ, Reggiori F, Mackay CR, Xavier RJ.

Immunity. 2016 Jun 21;44(6):1392-405. doi: 10.1016/j.immuni.2016.05.007. Epub 2016 Jun 7.

14.

Authors' Response.

Brickhouse B, Isaacs C, Batten M, Price A.

Nurs Womens Health. 2016 Jun-Jul;20(3):232. doi: 10.1016/j.nwh.2016.04.026. No abstract available.

PMID:
27287348
15.

Scalability of Continuous Flow Production of Metal-Organic Frameworks.

Rubio-Martinez M, Hadley TD, Batten MP, Constanti-Carey K, Barton T, Marley D, Mönch A, Lim KS, Hill MR.

ChemSusChem. 2016 May 10;9(9):938-41. doi: 10.1002/cssc.201501684. Epub 2016 Apr 14.

PMID:
27075923
16.

Strategies for Providing Low-Cost Water Immersion Therapy With Limited Resources.

Brickhouse B, Isaacs C, Batten M, Price A.

Nurs Womens Health. 2015 Dec-2016 Jan;19(6):526-32. doi: 10.1111/1751-486X.12247.

PMID:
26682659
17.

IL-21 and IL-4 Collaborate To Shape T-Dependent Antibody Responses.

McGuire HM, Vogelzang A, Warren J, Loetsch C, Natividad KD, Chan TD, Brink R, Batten M, King C.

J Immunol. 2015 Dec 1;195(11):5123-35. doi: 10.4049/jimmunol.1501463. Epub 2015 Oct 21.

18.

Versatile, high quality and scalable continuous flow production of metal-organic frameworks.

Rubio-Martinez M, Batten MP, Polyzos A, Carey KC, Mardel JI, Lim KS, Hill MR.

Sci Rep. 2014 Jun 25;4:5443. doi: 10.1038/srep05443.

19.

The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.

Parnell GP, Gatt PN, Krupa M, Nickles D, McKay FC, Schibeci SD, Batten M, Baranzini S, Henderson A, Barnett M, Slee M, Vucic S, Stewart GJ, Booth DR.

Clin Immunol. 2014 Mar;151(1):16-24. doi: 10.1016/j.clim.2014.01.003. Epub 2014 Jan 15.

20.

IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells.

Vogelzang A, McGuire HM, Liu SM, Gloss B, Mercado K, Earls P, Dinger ME, Batten M, Sprent J, King C.

J Immunol. 2014 Feb 15;192(4):1404-14. doi: 10.4049/jimmunol.1302285. Epub 2014 Jan 20.

21.

The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.

Shahijanian F, Parnell GP, McKay FC, Gatt PN, Shojoei M, O'Connor KS, Schibeci SD, Brilot F, Liddle C, Batten M; ANZgene Multiple Sclerosis Genetics Consortium, Stewart GJ, Booth DR.

Hum Mol Genet. 2014 Mar 15;23(6):1425-34. doi: 10.1093/hmg/ddt529. Epub 2013 Oct 24.

PMID:
24158849
22.

Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?

Swarbrick A, Junankar SR, Batten M.

Oncoimmunology. 2013 Aug 1;2(8):e25409. Epub 2013 Jul 1.

23.

Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.

Stolp J, Mariño E, Batten M, Sierro F, Cox SL, Grey ST, Silveira PA.

J Immunol. 2013 Jul 1;191(1):97-109. doi: 10.4049/jimmunol.1203252. Epub 2013 Jun 5.

24.

Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.

Natividad KD, Junankar SR, Mohd Redzwan N, Nair R, Wirasinha RC, King C, Brink R, Swarbrick A, Batten M.

PLoS One. 2013;8(3):e57469. doi: 10.1371/journal.pone.0057469. Epub 2013 Mar 12.

25.

The origins, function, and regulation of T follicular helper cells.

Ma CS, Deenick EK, Batten M, Tangye SG.

J Exp Med. 2012 Jul 2;209(7):1241-53. doi: 10.1084/jem.20120994. Review.

26.

Bystanders not so innocent after all.

Batten M, Ghilardi N.

Immunity. 2012 Jun 29;36(6):901-3. doi: 10.1016/j.immuni.2012.06.001.

27.

Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, Arkwright PD, Kreins AY, Averbuch D, Engelhard D, Magdorf K, Kilic SS, Minegishi Y, Nonoyama S, French MA, Choo S, Smart JM, Peake J, Wong M, Gray P, Cook MC, Fulcher DA, Casanova JL, Deenick EK, Tangye SG.

Blood. 2012 Apr 26;119(17):3997-4008. doi: 10.1182/blood-2011-11-392985. Epub 2012 Mar 8.

28.

IL-27 promotes T cell-dependent colitis through multiple mechanisms.

Cox JH, Kljavin NM, Ramamoorthi N, Diehl L, Batten M, Ghilardi N.

J Exp Med. 2011 Jan 17;208(1):115-23. doi: 10.1084/jem.20100410. Epub 2010 Dec 20.

29.

IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.

Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS, Danilenko DM, Caplazi P, Wong M, Fulcher DA, Cook MC, King C, Tangye SG, de Sauvage FJ, Ghilardi N.

J Exp Med. 2010 Dec 20;207(13):2895-906. doi: 10.1084/jem.20100064. Epub 2010 Nov 22.

30.

Lineage specification and heterogeneity of T follicular helper cells.

Yu D, Batten M, Mackay CR, King C.

Curr Opin Immunol. 2009 Dec;21(6):619-25. doi: 10.1016/j.coi.2009.09.013. Epub 2009 Nov 5. Review.

PMID:
19896816
31.

Daddy dearest.

Hrdy SB, Batten M.

Time. 2007 Jun 18;169(25):60, 62. No abstract available.

PMID:
18655542
32.

Long-term mutagenic effects of ionising radiation on mice which vary in their p53 status.

Fernandez HR, Batten M, Kugathasan K, Lutze-Mann LH.

DNA Repair (Amst). 2008 Apr 2;7(4):641-7. doi: 10.1016/j.dnarep.2008.01.004. Epub 2008 Mar 4.

PMID:
18304895
33.

Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.

Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N.

J Immunol. 2008 Mar 1;180(5):2752-6.

34.

Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.

Mariño E, Batten M, Groom J, Walters S, Liuwantara D, Mackay F, Grey ST.

Diabetes. 2008 Feb;57(2):395-404. Epub 2007 Nov 19.

35.

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.

Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M, Harvey RP, Martínez-A C, Mackay CR, Mackay F.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14759-64. Epub 2007 Sep 5.

36.

The biology and therapeutic potential of interleukin 27.

Batten M, Ghilardi N.

J Mol Med (Berl). 2007 Jul;85(7):661-72. Epub 2007 Feb 10. Review.

PMID:
17294231
37.

Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.

Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, Mackay F.

Eur J Immunol. 2006 Sep;36(9):2504-14.

38.

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N.

Nat Immunol. 2006 Sep;7(9):929-36. Epub 2006 Aug 13.

PMID:
16906167
39.

Structural requirements for the interaction of human IgA with the human polymeric Ig receptor.

Lewis MJ, Pleass RJ, Batten MR, Atkin JD, Woof JM.

J Immunol. 2005 Nov 15;175(10):6694-701.

40.

Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis.

Batten ML, Imanishi Y, Tu DC, Doan T, Zhu L, Pang J, Glushakova L, Moise AR, Baehr W, Van Gelder RN, Hauswirth WW, Rieke F, Palczewski K.

PLoS Med. 2005 Nov;2(11):e333. Epub 2005 Nov 1.

41.

Nonvisual photoreception in the chick iris.

Tu DC, Batten ML, Palczewski K, Van Gelder RN.

Science. 2004 Oct 1;306(5693):129-31.

43.

Dichloro(methanol-kappaO)[(methoxy)tris(1-methyl-1H-imidazol-2-yl)methane-kappa2N3]iron(II) (ca 153 K).

Batten MP, Canty AJ, Cavell KJ, Rüther T, Skelton BW, White AH.

Acta Crystallogr C. 2004 Jul;60(Pt 7):m314-5. Epub 2004 Jun 22.

PMID:
15237145
45.

Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye.

Imanishi Y, Batten ML, Piston DW, Baehr W, Palczewski K.

J Cell Biol. 2004 Feb 2;164(3):373-83. Epub 2004 Jan 26.

46.

TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.

Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laâbi Y, Xin X, Schneider P, Tschopp J, Mackay CR, Mackay F.

J Immunol. 2004 Jan 15;172(2):812-22.

47.

Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver.

Batten ML, Imanishi Y, Maeda T, Tu DC, Moise AR, Bronson D, Possin D, Van Gelder RN, Baehr W, Palczewski K.

J Biol Chem. 2004 Mar 12;279(11):10422-32. Epub 2003 Dec 18.

48.

Retinoid cycle in the vertebrate retina: experimental approaches and mechanisms of isomerization.

Kuksa V, Imanishi Y, Batten M, Palczewski K, Moise AR.

Vision Res. 2003 Dec;43(28):2959-81.

49.

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).

Thomson KL, Gloyn AL, Colclough K, Batten M, Allen LI, Beards F, Hattersley AT, Ellard S.

Hum Mutat. 2003 Nov;22(5):417.

PMID:
14517956
50.

Supplemental Content

Loading ...
Support Center